Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Patriot One to Present at Canaccord Genuity’s 40th Annual Growth Conference
-
Identiv to Present at Canaccord Genuity’s 40th Annual Growth Conference on August 13, 2020 at 8 AM ET
-
HMS to Present at the Canaccord Genuity Growth Conference on August 12th
-
Cardinal Resources Limited: Lodgement of Target’s Statement and Minimum Deposit Period
-
TILT Holdings to Present at Canaccord Genuity’s 40th Annual Growth Conference
-
Quanterix to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
TILT Holdings to Present at Canaccord Genuity’s 40th Annual Growth Conference
-
Medexus Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th
-
Genasys™ Inc. to Participate in Canaccord 40th Annual Growth Conference
-
Medexus Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th
-
Genasys™ Inc. to Participate in Canaccord 40th Annual Growth Conference
-
MineralTree CFO to Speak at Two Investor Conferences
-
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
TransGlobe Energy Corporation Announces Second Quarter 2020 Financial and Operating Results for the Three and Six Months Ended June 30, 2020
-
AdaptHealth Corp. to Participate in Fireside Chat at Canaccord Genuity 40th Annual Growth Conference
-
X4 Pharmaceuticals to Present and Participate in the Canaccord Genuity’s 40th Annual Growth Conference
-
Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Sprout Social (SPT) Announces Launch of Follow-on Public Offering
-
Impinj to Participate in Upcoming Virtual Investor Conference
-
Sprout Social Announces Launch of Follow-on Public Offering
-
Health Catalyst to Participate in Upcoming Investor Conferences
-
Health Catalyst to Participate in Upcoming Investor Conferences
-
KORU Medical Systems to Present at Canaccord Genuity 40th Annual Growth Conference
-
Dexcom Announces Upcoming Conference Presentation
-
Cara Therapeutics Reports Second Quarter 2020 Financial Results
-
Cara Therapeutics Reports Second Quarter 2020 Financial Results
-
Upwork To Present at the Canaccord Genuity Global Growth Conference
-
Upwork To Present at the Canaccord Genuity Global Growth Conference
-
Seres Therapeutics (MCRB) PT Raised to $38 at Canaccord Genuity, Following Drug Trial Results
-
Intellicheck to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
Synchronoss Technologies (SNCR) PT Raised to 'Street High' $11 at Canaccord Genuity on Verizon Renewal
-
Hamilton Thorne to Present at Canaccord Genuity 40th Annual Growth Conference
-
Hamilton Thorne to Present at Canaccord Genuity 40th Annual Growth Conference
-
Everbridge to Present at Canaccord Genuity Growth Conference
-
Digital Media Solutions, Inc. Announces Participation in the Canaccord Genuity 40th Annual Growth Conference
-
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
-
Fluent, Inc. to Present at the 40th Annual Canaccord Genuity Growth Conference
-
Canaccord Genuity Starts Verona Pharma (VRNA) at Buy
-
Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference
-
AirBoss to Present at Canaccord Genuity’s 40th Annual Growth Conference
-
ShotSpotter to Present at Canaccord Genuity’s 40th Annual Growth Conference on August 12, 2020 at 9:30 a.m. ET
-
Orca Energy Group Inc. Provides Operational and Corporate Update
-
AirBoss to Present at Canaccord Genuity’s 40th Annual Growth Conference
-
Profound Medical Present at the Canaccord Genuity 40th Annual Growth Conference
-
BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
-
Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 40th Annual Growth Conference
-
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
-
BigCommerce Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
TraceSafe Closes $4M Private Placement: Current Capital Needs Met, Order Pipeline Strong

